Literature DB >> 9641645

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.

M Chen1, M Shirai, A J Czaja, K Kurokohchi, T Arichi, K Arima, T Kodama, M Nishioka.   

Abstract

We have recently found that antibodies to total histones are common in a group of American patients with type 1 autoimmune hepatitis (AIH). In an attempt to determine the profile and clinical association of anti-histone antibody (AHA), 45 Japanese AIH patients were studied for serum isotypic reactivity with individual histones (H1, H2A, H2B, H3, H4) by enzyme-linked immunosorbent assay and western blotting. The results revealed that 40% of sera had reactivities with at least one of individual histones and that the antibodies were detected in all three classes of immunoglobulins (IgG, IgM, IgA). Immunoglobulin G type anti-H3 showed the dominant reactivity and it characterized 72% of sera with AHA. The titre of anti-H3 decreased significantly (P < 0.0075) after steroid therapy and the index of decrease for anti-H3 was correlated in individuals with that for serum aminotransferase. In general, patients with AHA showed higher serum level of alanine aminotransferase (P < 0.05), immunoglobulin G (P < 0.025), and higher frequency of A2-DR4 haplotype (53 vs 17%) than their seronegative counterparts. However, the titre of AHA was low in this disease condition and histone class-specific antibodies did not distinguish patients with distinctive clinical features, although patients with anti-H3 tended to be younger than those without AHA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9641645     DOI: 10.1111/j.1440-1746.1998.tb00673.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

3.  Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.

Authors:  M Chen; M Shirai; Z Liu; T Arichi; H Takahashi; M Nishioka
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 4.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

5.  Frequency and significance of antibodies to chromatin in autoimmune hepatitis.

Authors:  Albert J Czaja; Zakera Shums; Walter L Binder; Stephen J Lewis; Vicki J Nelson; Gary L Norman
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 6.  Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.

Authors:  Takashi Himoto; Mikio Nishioka
Journal:  Auto Immun Highlights       Date:  2013-02-22

Review 7.  Epigenetics in inflammatory liver diseases: A clinical perspective (Review).

Authors:  Teodora Isac; Sebastian Isac; Razvan Rababoc; Mihail Cotorogea; Laura Iliescu
Journal:  Exp Ther Med       Date:  2022-04-04       Impact factor: 2.751

8.  Antihistone Autoantibodies in Dobermans With Hepatitis.

Authors:  H Dyggve; S Meri; T Spillmann; H Jarva; M Speeti
Journal:  J Vet Intern Med       Date:  2017-09-30       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.